Could a single shot ease your back pain? new cell therapy tested

NCT ID NCT03955315

Summary

This early-stage study tested the safety and initial effectiveness of a new cell-based injection (IDCT) for people with chronic low back pain caused by a worn-out spinal disc. 38 participants with long-term pain that didn't improve with standard care received either one of two doses of the cell injection or a sham (placebo) procedure. Researchers tracked participants for a year to see if the treatment reduced pain and disability compared to the sham.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Chiba University Hospital

    Chuo-ku, Chiba, 260-8670, Japan

  • Mie University Hospital

    Tsu, Mie-ken, 514-8507, Japan

  • Nagoya university hospital

    Shōwaku, Nagoya, 466-8550, Japan

  • Osaka University Hospital

    Suita, Osaka, 565-0871, Japan

  • Tokai University Hospital

    Isehara, Kanagawa, 259-1193, Japan

  • University of Yamanashi Hospital

    Chūō, Yamanashi, 409-3898, Japan

Conditions

Explore the condition pages connected to this study.